FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved a supplemental application for WELLBUTRIN SR (bupropion hydrochloride) from GlaxoSmithKline, updating the labeling through a supplemental approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Seasonal Affective Disorder

Drugs mentioned

• WELLBUTRIN SR (BUPROPION HYDROCHLORIDE)

Snippet

SUPPL AP for WELLBUTRIN SR (BUPROPION HYDROCHLORIDE)